Inici › Càncer metastàtic › Washington › Seattle
Assaigs clínics de Càncer metastàtic a Seattle, WA
39 estudis de Càncer metastàtic busquen participants en centres de Seattle i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutantFase 2
- Swedish Medical Center-First Hill, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutantFase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
ReclutantFase 3
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
ReclutantFase 1
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ReclutantFase 1
- Fred Hutchinson Cancer Center, Seattle
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ReclutantFase 2/3
- Fred Hutchinson Cancer Center, Seattle
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutantFase 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center, Seattle
- i 1 més
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
ReclutantFase 1
- Swedish Cancer Institute, Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutantFase 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ReclutantFase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
ReclutantFase 1/2
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutantFase 3
- Swedish Medical Center, Seattle
SLV-154 Treatment of Advanced Cancers
ReclutantFase 1
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutantFase 3
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
ReclutantFase 1/2
- Fred Hutchinson Cancer Center, Seattle
- University Of Washington Medical Center, Seattle
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
ReclutantFase 1/2
- Fred Hutchinson Cancer Center ( Site 0013), Seattle
A Study of KK2269 in Adult Participants With Solid Tumors
ReclutantFase 1
- University of Washington, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutantFase 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
ReclutantFase 1/2
- Avenzo Therapeutics Recruiting Site, Seattle
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
ReclutantFase 1
- Fred Hutchinson Cancer Research Center, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
ReclutantVoluntaris sans benvinguts
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
ReclutantFase 1
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutantFase 3
- Research Site, Seattle
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
ReclutantFase 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
ReclutantFase 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
ReclutantFase 2
- VA Puget Sound Health Care System, Seattle
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
ReclutantFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
ReclutantFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
ReclutantFase 3
- Fred Hutchinson Cancer Center, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutantFase 1/2
- Virginia Mason Medical Center, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ReclutantFase 1/2
- Virginia Mason Medical Center, Seattle
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
ReclutantFase 2/3
- Fred Hutchinson Cancer Research Center, Seattle
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutantFase 2/3
- Fred Hutchinson Cancer Center, Seattle
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
ReclutantFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutantFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
ReclutantFase 1
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Seattle
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
ReclutantFase 1
- Fred Hutch Cancer Center, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutantFase 1
- Fred Hutchinson Cancer Center, Seattle
Assaigs de Càncer metastàtic en altres ciutats
- Houston, TX104 estudis
- New York City, NY93 estudis
- Nashville, TN70 estudis
- Boston, MA63 estudis
- Los Angeles, CA57 estudis
- St. Louis, MO54 estudis
- Arlington, VA53 estudis
- Philadelphia, PA46 estudis
- Chicago, IL45 estudis
- San Antonio, TX44 estudis
- Washington, DC43 estudis
- Dallas, TX42 estudis
Altres estudis a Seattle
- Càncer de pulmó de cèl·lules no petites53 estudis
- Càncer (tots els tipus)49 estudis
- Càncer de pròstata42 estudis
- Leucèmia mieloide aguda40 estudis
- Càncer de mama39 estudis
- Càncer colorrectal34 estudis
- Càncer de pulmó33 estudis
- Càncer d'ovari30 estudis
- Mieloma múltiple22 estudis
- Síndromes mielodisplàsiques21 estudis
- Leucèmia limfoblàstica aguda21 estudis
- Càncer de bufeta21 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.